Aethlon Medical
AEMD
9 hedge funds and large institutions have $87.3K invested in Aethlon Medical in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
0% less ownership
Funds ownership: 0.03% → 0.02% (-0%)
10% less funds holding
Funds holding: 10 → 9 (-1)
23% less capital invested
Capital invested by funds: $114K → $87.3K (-$26.6K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
+$144 |
Top Sellers
| 1 |
Group One Trading
Chicago,
Illinois
|
-$144 |
| 2 |
Morgan Stanley
New York
|
-$144 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Vanguard Group
Malvern,
Pennsylvania
| $35.7K | – | – | – |
|
2
Geode Capital Management
Boston,
Massachusetts
| $34.1K | – | – | – |
|
3
BlackRock
New York
| $12.3K | – | – | – |
|
|
4
Group One Trading
Chicago,
Illinois
| $2.04K | -$144 | -1 | -6% |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| $1.91K | – | – | – |
|
6
Osaic Holdings
Scottsdale,
Arizona
| $501 | – | – | – |
|
7
Wells Fargo
San Francisco,
California
| $386 | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $225 | +$144 | +1 | +100% |
|
|
9
Morgan Stanley
New York
| $150 | -$144 | -1 | -50% |
|
|
BCWM
10
Bartlett & Co Wealth Management
Cincinnati,
Ohio
| $44 | – | – | – |
|
AEMD Hedge Fund Activity: Q1 2024 in Review
9 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2024, worth a combined $87.3K — down 23% from $114K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AEMD and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was UBS Group, adding an estimated $144. The largest seller was Group One Trading, cutting an estimated $144.
- 9 institutional investors held Aethlon Medical (AEMD) as of Q1 2024, down from 10 in Q4 2023.
- Funds reported $87.3K of Aethlon Medical stock for Q1 2024, down 23% quarter-over-quarter.
- 0 funds opened new Aethlon Medical positions in Q1 2024 and 1 closed out, a net change of -1 holder.
- The largest Aethlon Medical buyer in Q1 2024 was UBS Group, an estimated $144 added.
- The largest Aethlon Medical seller in Q1 2024 was Group One Trading, an estimated $144 sold.
Based on aggregated 13F filings for Q1 2024.